Security Snapshot

Prestige Consumer Healthcare Inc. - Common Stock (PBH) Institutional Ownership

CUSIP: 74112D101

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

350

Shares (Excl. Options)

51,951,754

Price

$59.27

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+401,729
Value change
+$20,240,887
Number of holders
350
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
47,393,320
SEC-reported price per share
$54.31
Insider filing price
$54.31
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • PBH - Prestige Consumer Healthcare Inc. - Common Stock is tracked under CUSIP 74112D101.
  • 350 institutions reported positions in Q1 2026.
  • 6 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 353 to 350 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $3,184,296,301 to $3,075,761,803.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 350 institutions filings for Q1 2026.

Open SEC evidence

Security key

74112D101

Latest holder period

Q1 2026

13F holders

350

13D/G owners

6

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
6
Security
PBH
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15% $609,115,318 7,524,587 BlackRock, Inc. 31 Mar 2025
ARIEL INVESTMENTS, LLC 8.5% +17% $251,154,866 +$31,071,476 4,102,497 +14% Ariel Investments, LLC 31 Dec 2025
DIMENSIONAL FUND ADVISORS LP 5.9% $235,326,993 2,907,066 Dimensional Fund Advisors LP 31 Dec 2024
VANGUARD PORTFOLIO MANAGEMENT LLC 6% $167,528,789 2,826,536 Vanguard Portfolio Management 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $145,506,309 2,454,974 Vanguard Capital Management 31 Mar 2026
MACQUARIE GROUP LTD 4.7% $186,914,926 2,309,017 Macquarie Group Limited 31 Dec 2024

As of 31 Mar 2026, 350 institutional investors reported holding 51,951,754 shares of Prestige Consumer Healthcare Inc. - Common Stock (PBH). This represents 110% of the company’s total 47,393,320 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
81%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 7,388,490 -3.6% 0.01% $437,915,786
ARIEL INVESTMENTS, LLC 9% 4,274,326 +4.2% 2.8% $253,339,302
VANGUARD PORTFOLIO MANAGEMENT LLC 5.9% 2,803,828 0% 0.01% $166,182,886
DIMENSIONAL FUND ADVISORS LP 5.6% 2,672,777 +3.6% 0.03% $158,413,538
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 4.6% 2,202,606 +3% 0.38% $130,548,458
VANGUARD CAPITAL MANAGEMENT LLC 4.4% 2,092,993 0% 0% $124,051,695
STATE STREET CORP 4.2% 1,970,981 -1.1% 0% $116,820,044
Allspring Global Investments Holdings, LLC 3.3% 1,558,104 -3.4% 0.15% $89,871,438
GEODE CAPITAL MANAGEMENT, LLC 3.1% 1,460,035 +2% 0.01% $86,547,398
MORGAN STANLEY 2.9% 1,357,470 +13% 0% $80,457,292
WESTWOOD HOLDINGS GROUP INC 2.4% 1,119,715 -5.1% 0.48% $66,365,506
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 2.3% 1,070,515 -25% 0.11% $63,449,000
Capital Research Global Investors 1.9% 894,679 +59% 0.01% $53,027,624
BRANDES INVESTMENT PARTNERS, LP 1.8% 854,119 +41% 0.36% $50,623,633
NORTHERN TRUST CORP 1.6% 750,305 +2.9% 0.01% $44,470,578
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.6% 742,149 +0.47% 0.01% $43,987,171
Boston Trust Walden Corp 1.4% 643,340 -9.9% 0.31% $38,130,762
NORDEA INVESTMENT MANAGEMENT AB 1.3% 599,375 -2.6% 0.03% $35,087,412
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.3% 598,026 -8.1% 0.01% $35,445,001
Invesco Ltd. 1.3% 595,998 +2.1% 0.01% $35,324,802
RAYMOND JAMES FINANCIAL INC 1.2% 556,460 -8.9% 0.01% $32,710,050
BANK OF AMERICA CORP /DE/ 1.2% 547,442 -3.3% 0% $32,446,888
PRICE T ROWE ASSOCIATES INC /MD/ 1.2% 546,209 -2.2% 0% $32,375,000
RICE HALL JAMES & ASSOCIATES, LLC 1.1% 521,622 +4.2% 1.7% $30,916,536
SILVERCREST ASSET MANAGEMENT GROUP LLC 1% 480,408 0.21% $28,474,046

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Rows shown
1-25 of 49
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 51,951,754 $3,075,761,803 +$20,240,887 $59.27 350
2025 Q4 51,625,243 $3,184,296,301 -$39,666,152 $61.69 353
2025 Q3 50,810,480 $3,171,948,668 -$74,667,802 $62.40 351
2025 Q2 52,028,208 $4,154,947,022 +$68,664,201 $79.85 372
2025 Q1 51,179,850 $4,399,098,887 -$94,834,306 $85.97 354
2024 Q4 52,470,130 $4,096,580,344 +$88,611,492 $78.09 335
2024 Q3 51,041,422 $3,683,307,685 +$3,200,629 $72.10 323
2024 Q2 51,067,584 $3,515,715,953 -$4,889,638 $68.85 305
2024 Q1 51,320,692 $3,722,982,898 +$23,075,777 $72.56 311
2023 Q4 51,115,027 $3,129,318,451 +$6,370,695 $61.22 287
2023 Q3 50,946,303 $2,913,995,592 +$55,643,279 $57.19 279
2023 Q2 49,864,351 $2,965,000,913 -$29,425,137 $59.43 273
2023 Q1 50,365,220 $3,154,009,517 +$46,802,032 $62.63 280
2022 Q4 50,007,293 $3,131,794,375 +$2,107,559 $62.60 286
2022 Q3 50,088,729 $2,496,799,721 -$37,445,090 $49.83 270
2022 Q2 50,591,595 $2,974,240,060 +$45,867,050 $58.80 273
2022 Q1 50,360,901 $2,667,571,389 -$38,075,618 $52.94 269
2021 Q4 50,531,110 $3,065,040,827 -$86,724,122 $60.65 261
2021 Q3 50,742,397 $2,847,713,877 -$66,715,011 $56.11 240
2021 Q2 51,943,459 $2,706,851,067 -$30,851,217 $52.10 219
2021 Q1 52,622,155 $2,319,703,648 +$13,619,119 $44.08 233
2020 Q4 52,481,635 $1,830,396,086 -$33,067,279 $34.87 227
2020 Q3 53,391,500 $1,942,255,015 -$69,442,046 $36.42 233
2020 Q2 55,276,415 $2,075,158,514 +$31,352,635 $37.56 248
2020 Q1 54,484,428 $1,999,030,159 -$232,050,557 $36.68 242
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .